ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Biotechnology Advances
Volume 23, Issue 6, September 2005, Pages 401-408
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (347 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.biotechadv.2005.05.005    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2005 Elsevier Inc. All rights reserved.

Research review paper

Coeliac Disease: Background and biochemical aspects

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Rob. J. HamerE-mail The Corresponding Author

Centre for Protein Technology, WUR Wageningen, The Netherlands

TNO Quality of Life, Zeist, The Netherlands


Received 1 March 2005; 
accepted 13 May 2005. 
Available online 11 July 2005.

Abstract

Coeliac Disease has to be considered a main food related affliction, with life long consequences for the people having the disease. Coeliac Disease patients suffer from adverse effects that can be related to specific gluten peptide sequences that trigger a sequence of immune related reactions leading to damage of the intestine and related malabsorption symptoms. Recently, detailed information has come available on peptide sequences that are toxic for Coeliac Disease patients. This information is discussed in relation to prevention of the disease and the development of safe cereals for Coeliac Disease patients.

Keywords: Coeliac Disease; Gluten; Peptides

Article Outline

1. Introduction
1.1. Background of the disease
2. Diagnosis of CD
2.1. Genetic aspects of CD
2.2. Toxic mechanism
2.3. CD vs IgE-mediated allergy
3. CD is related to the toxic effect of certain gluten proteins
3.1. Composition of wheat proteins
3.2. Discovery of a toxic sequence
3.3. T-cell tests
3.4. Searching for toxic peptides
4. The feasibility of making a CD-safe gluten
5. The gluten free diet
6. Concluding remarks
References




Biotechnology Advances
Volume 23, Issue 6, September 2005, Pages 401-408
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.